Aethlon Medical Inc. of San Diego has formed a relationship with Kentucky Bioprocessing to establish processes that will support Aethlon’s Hemopurifier®, a medical device that absorbs viruses and immunosuppressive particles from the bloodstream. “The relationship with Kentucky Bioprocessing represents an important step towards establishing the long-term commercial feasibility of our Hemopurifier®, said Aethlon Medical CEO Jim Joyce. “Beyond a significant cost reduction of our affinity agents, the relationship offers large-yield production potential in time frames that could improve our response capability against viral outbreaks, including unforeseen bioterror and pandemic threats.”
-
Share This!
Owensboro
November 1, 2009
377 Views
You may also like
Popular Stories
Lee and Hayley return to Kentucky mornings
August 16, 2022
Kentucky housing market is shifting
August 15, 2022
Jewish Hospital announces Cash as new COO
August 15, 2022
Cox joins cooperatives’ economic development team
August 16, 2022
Add Comment